Dare Bioscience, Inc. (DARE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Dare Bioscience, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -16.10x | -6.54x | -0.95x | -2.27x | -3.16x | -1.47x |
| P/B Ratio | 75.90x | -4.41x | -5.69x | 6.32x | 3.16x | -35.02x |
| P/S Ratio | 209.43x | 2709.59x | 10.23x | 7.02x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | -137.5% | -146110.2% | -670.6% | -201.4% | 0.0% | 0.0% |
| Operating Margin | -1315.5% | -239692.2% | -1101.9% | -313.9% | 0.0% | 0.0% |
| Net Margin | -1300.7% | -41430.9% | -1074.2% | -309.5% | 0.0% | 0.0% |
| EBITDA Margin | -1106.7% | -239259.6% | -1093.4% | -313.6% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.14x | 0.85x | 0.86x | 1.36x | 3.44x | 0.91x |
| Quick Ratio | 1.14x | 0.85x | 0.86x | 1.36x | 3.44x | 0.91x |
| Leverage | ||||||
| Debt/Equity | 0.93x | -0.22x | -0.28x | 0.04x | 0.01x | -0.66x |
YoY = year-over-year change. Source: FMP..